Matches in Nanopublications for { ?s ?p "[We revealed that, apart from E-cadherin in Leydig cell tumors and calretinin in seminomas, the expression of all the analyzed markers in canine and human testicular tumors was similar.E.g. there was no immunoexpression of inhibin-? in 75% of canine and 100% of human cases of seminoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP1248316.RAdCOq3fKqqLWFgCnwooNYMomf6U1dCeL2Q2jXAwVnOVw130_assertion description "[We revealed that, apart from E-cadherin in Leydig cell tumors and calretinin in seminomas, the expression of all the analyzed markers in canine and human testicular tumors was similar.E.g. there was no immunoexpression of inhibin-? in 75% of canine and 100% of human cases of seminoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248316.RAdCOq3fKqqLWFgCnwooNYMomf6U1dCeL2Q2jXAwVnOVw130_provenance.
- NP1248317.RA-cnNE6Vqdd5dUlryMFzQjVmoQk6rT0oxPnGqmfP3qrw130_assertion description "[We revealed that, apart from E-cadherin in Leydig cell tumors and calretinin in seminomas, the expression of all the analyzed markers in canine and human testicular tumors was similar.E.g. there was no immunoexpression of inhibin-? in 75% of canine and 100% of human cases of seminoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248317.RA-cnNE6Vqdd5dUlryMFzQjVmoQk6rT0oxPnGqmfP3qrw130_provenance.
- NP1248322.RA8v4qys4lUtvADHdC2ap8CsAdhe--_iY-MxwXgmtg8V0130_assertion description "[We revealed that, apart from E-cadherin in Leydig cell tumors and calretinin in seminomas, the expression of all the analyzed markers in canine and human testicular tumors was similar.E.g. there was no immunoexpression of inhibin-? in 75% of canine and 100% of human cases of seminoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248322.RA8v4qys4lUtvADHdC2ap8CsAdhe--_iY-MxwXgmtg8V0130_provenance.